For correct coding and usage, it is important to consult the latest official references, such as the ICD-10-CM manual, ACOGs OB/GYN Coding Manual, the AMAs Current Procedural Terminology Professional Edition, and HCPCS coding resources
doi: 10.1111/j.1462-5822.2006.00836.x 83 SouzaLElianSDPaulaLMGarciaCCVieiraATTeixeiraMMet al
Dosing Recommendations While human clinical trial data remains limited, current evidence-based recommendations derived from animal studies and clinical experience suggest: General anti-inflammatory dosing: 200-500 mcg administered subcutaneously once daily or 500-1000 mcg twice weekly Acute injury management: Higher doses (500-1000 mcg) may be used daily initially, with tapering to maintenance doses Route of administration: Both systemic (subcutaneous/intramuscular) and local (perilesional) injections have shown similar efficacy
- Mast cells help generate and release histamine
In Phase I, the liver breaks down toxins into smaller, often more reactive intermediates